PERSONALIZED PHARMACOLOGICAL CORRECTION OF IMMUNE SYSTEMS, METABOLIC AND NEUROPSYCHIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA OF STAGE I AND II ON THE BACKGROUND OF HYPERTENSION DISEASE
The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI) stages I and II. The study included 104 patients, of which 76 were female and 28 were male, with CCI on the background of grade II hypertension,...
Saved in:
| Main Authors: | A. I. Konoplya, A. A. Shulginova, N. A. Bystrova, V. P. Gavrilyuk, G. N. Ryzhikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2021-10-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/1988 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DRUG NEUROPROTECTION IN FULL-TERM NEWBORNS WITH SEVERE CEREBRAL ISCHEMIA
by: A. A. Zadvornov, et al.
Published: (2018-01-01) -
ALGORITHM OF PSYCHOLOGICAL AND PSYCHOTHERAPEUTIC SUPPORT OF PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA
by: I. V. Khianikiainen, et al.
Published: (2018-06-01) -
Aged lipid‐laden microglia display impaired responses to stroke
by: Maria Arbaizar‐Rovirosa, et al.
Published: (2022-12-01) -
Actovegin in the treatment of patients with cognitive impairments in the chronic cerebral ischemia
by: L. M. Boriskina
Published: (2015-12-01) -
The application of vicasole as a perspective nephrolithyiasis pharmacological correction’s drug
by: A. Yu. Zharikov, et al.
Published: (2012-02-01)